Abstract
This letter describes the design, development and SAR exploration of a novel series of small legumain inhibitors. The SAR of a new small molecule legumain inhibitor chemotype was explored and found to have improved physiochemical properties compared to previously developed inhibitors within our group. However, further development of this series was found to be limited as the SAR was observed to be relatively flat.
Original language | English |
---|---|
Pages (from-to) | 413-6 |
Number of pages | 4 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 26 |
Issue number | 2 |
Early online date | 28 Nov 2015 |
DOIs | |
Publication status | Published - 15 Jan 2016 |